Skip to content

Investigation the effect of relaxtation on miR-21 expression and serum levels of IL-10 and IFN-? in patients infected with COVID-19

Investigation the effect of relaxtation on miR-21 expression and serum levels of IL-10 and IFN-? in patients infected with COVID-19

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210413050959N1
Enrollment
40
Registered
2021-08-17
Start date
2021-08-23
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 disease.

Interventions

Intervention group: patiants who listen to sedative audio file..

Sponsors

Rafsanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patiants whose disease have been confirmed in terms of clinical findings and CT scan findings as well as RT-PCR test by a specialist Confirmation of pneumonia by chest x-ray Blood oxygen saturation below 93% Relative stability of cardiovascular status

Exclusion criteria

Exclusion criteria: Disapproval of RT-PCR test Dissatisfaction of patiants The opinion of the treating physician to exclude the patient from the study Decreased blood oxygen saturation below 85% while using a ventilator or nasal passage People with underlying diseases

Design outcomes

Primary

MeasureTime frame
Serum levels of IL-10, MIR-21 and IFN-? and patients' stress scores are measured before and after the intervention (listening to the audio file). Timepoint: Serum levels of IL-10, MIR-21 and IFN-? are measured before the intervention and 5 to 6 days after the intervention (listening to the audio file). Method of measurement: Patients' stress levels and serum levels of IL-10, MIR-21 and IFN-? F are measured using questionnaire and ELISA technique respectively.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Amin

Rafsanjan University of Medical Sciences

ft.amin@yahoo.com+98 34 3428 0041

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026